Dr Susan Windham-Bannister

President and CEO at Massachusetts Life Sciences Centre

President and CEO, Massachusetts Life Sciences Center
Policy Fellow Alum, Centre for Science and Policy

Dr Windham-Bannister is the first President and CEO of the Massachusetts Life Sciences Center (MLSC), a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a ten-year, US$1 billion initiative signed into law in June 2008. Since assuming this position in July 2008, she has been responsible for the overall implementation of the initiative, including staffing, developing policies and procedures, creating a brand, and formulating the investment strategy. The Center's portfolio of investments is promoting economic development, catalysing innovation, strengthening Massachusetts' global leadership position in the life sciences, and accelerating the commercialisation of promising treatments, therapies and cures. Under her leadership the Center has invested US$218 million, leveraged another US$700 million in matching investment capital, and created over 7000 new life sciences jobs in the Commonwealth.

Before assuming her role at MLSC, Dr Windham-Bannister was a founding partner of Abt Bio-Pharma Solutions, a boutique consulting firm serving life sciences companies. In her 35-year consulting career, she and has been instrumental in the successful launch of a number of well-known therapeutics, medical devices and novel biomarkers. She has co-authored two books: Competitive Strategy for Health Care Organizations, and Medicaid and Other Experiments in State Health Policy. She also has written numerous articles on competition in today's healthcare marketplace.

Dr Windham-Bannister holds a BA from Wellesley College and a PhD in health policy and management from the Florence Heller School at Brandeis University, and was a post-doctoral fellow at Harvard University's John F. Kennedy School. She completed her doctoral work under a fellowship from the Ford Foundation.